Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Conditions:   NVP Plasma Level;   NVP Related Mutation;   3TC Related MutationIntervention:   Drug: AZT/3TC 2 weeks after deliverySponsors:   Thai Red Cross AIDS Research Centre;   Chulalongkorn University;   Queen Savang Vadhana Memorial Hospital, ThailandRecruiting - verified September 2009
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials